Wellington Management Group LLP Cytokinetics Inc Transaction History
Wellington Management Group LLP
- $531 Billion
- Q4 2024
A detailed history of Wellington Management Group LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,888,697 shares of CYTK stock, worth $363 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,888,697
Previous 7,774,970
1.46%
Holding current value
$363 Million
Previous $411 Million
9.61%
% of portfolio
0.07%
Previous 0.07%
Shares
19 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$675 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$548 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$495 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$284 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$131 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.33B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...